TLR7, IFNc, and T-bet: Their roles in the development of ABCs in femalebiased autoimmunity

Cellular Immunology

Volumn 294, Issue 2, 2015, Pages 80-83

  Rubtsova, Kira ^a,b   Marrack, Philippa ^a,b,c,d   Rubtsov, Anatoly V ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

ABCs; Autoimmunity; Gender; IFNgamma; T bet; TLR7

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR T BET; GLYCOPROTEIN P 15095; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21; TLR7 PROTEIN, HUMAN;

AGE ASSOCIATED B CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; X CHROMOSOME; ANIMAL; AUTOIMMUNE DISEASE; BIOSYNTHESIS; GENE DOSAGE; GENETICS; IMMUNOLOGY; MOUSE; SEXUAL DEVELOPMENT; ANTIBODY PRODUCTION; CELL MATURATION; CELLULAR IMMUNITY; HUMORAL IMMUNITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; Y CHROMOSOME;

ANIMALS; ANTIGENS, CD11C; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; FEMALE; GENE DOSAGE; HUMANS; INTERFERON-GAMMA; MICE; SEX CHARACTERISTICS; T-BOX DOMAIN PROTEINS; TOLL-LIKE RECEPTOR 7;

EID: 84933051921     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.12.002     Document Type: Article

References (48)

1. S. Oertelt-Prigione, The influence of sex and gender on the immune response, Autoimmun. Rev. 11 (2012) A479-A485.
2. E.N. Fish, The X-files in immunity: sex-based differences predispose immune responses, Nat. Rev. Immunol. 8 (2008) 737-744.
3. A.V. Rubtsov, K. Rubtsova, J.W. Kappler, P. Marrack, Genetic and hormonal factors in female-biased autoimmunity, Autoimmun. Rev. 9 (2010) 494-498.
4. M. Muenchhoff, P.J. Goulder, Sex differences in pediatric infectious diseases, J. Infect. Dis. 209 (Suppl. 3) (2014) S120-S126.
5. L.T. van Eijk, M.J. Dorresteijn, P. Smits, J.G. van der Hoeven, M.G. Netea, P. Pickkers, Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers, Crit. Care Med. 35 (2007) 1464-1469.
6. A. Bouman, M.J. Heineman, M.M. Faas, Sex hormones and the immune response in humans, Human Reprod. Update 11 (2005) 411-423.
7. J. Mossong, C.J. O'Callaghan, S. Ratnam, Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population, Vaccine 19 (2000) 523-529.
8. N.A. Young, L.C. Wu, C.J. Burd, A.K. Friedman, B.H. Kaffenberger, M.V. Rajaram, L.S. Schlesinger, H. James, M.A. Shupnik, W.N. Jarjour, Estrogen modulation of endosome-associated toll-like receptor 8: an IFNalpha-independent mechanism of sex-bias in systemic lupus erythematosus, Clin. Immunol. 151 (2014) 66-77.
9. R. Panchanathan, H. Liu, D. Choubey, Expression of murine Unc93b1 is upregulated by interferon and estrogen signaling: implications for sex bias in the development of autoimmunity, Int. Immunol. 25 (2013) 521-529.
10. H. Shen, R. Panchanathan, P. Rajavelu, X. Duan, K.A. Gould, D. Choubey, Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity, J. Mol. Cell Biol. 2 (2010) 284-290.
11. L. Yurkovetskiy, M. Burrows, A.A. Khan, L. Graham, P. Volchkov, L. Becker, D. Antonopoulos, Y. Umesaki, A.V. Chervonsky, Gender bias in autoimmunity is influenced by microbiota, Immunity 39 (2013) 400-412.
12. L. Carrel, H.F. Willard, X-inactivation profile reveals extensive variability in Xlinked gene expression in females, Nature 434 (2005) 400-404.
13. D.A. Gonzalez, B.B. Diaz, C. Rodriguez Perez Mdel, A.G. Hernandez, B.N. Chico, A.C. de Leon, Sex hormones and autoimmunity, Immunol. Lett. 133 (2010) 6-13.
14. G.C. Hughes, D. Choubey, Modulation of autoimmune rheumatic diseases by oestrogen and progesterone, Nat. Rev. Rheumatol. (2014).
15. M. Cutolo, A. Sulli, S. Capellino, B. Villaggio, P. Montagna, B. Seriolo, R.H. Straub, Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity, Lupus 13 (2004) 635-638.
16. Y. Hao, P. O'Neill, M.S. Naradikian, J.L. Scholz, M.P. Cancro, A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice, Blood 118 (2011) 1294-1304.
17. A.V. Rubtsov, K. Rubtsova, A. Fischer, R.T. Meehan, J.Z. Gillis, J.W. Kappler, P. Marrack, Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity, Blood 118 (2011) 1305-1315.
18. K. Rubtsova, A.V. Rubtsov, L.F. van Dyk, J.W. Kappler, P. Marrack, T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance, Proc. Natl. Acad. Sci. U.S.A. (2013).
19. S.R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R.A. Flavell, M.J. Shlomchik, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity 25 (2006) 417-428.
20. R.D. Pawar, A. Ramanjaneyulu, O.P. Kulkarni, M. Lech, S. Segerer, H.J. Anders, Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus, J. Am. Soc. Nephrol. 18 (2007) 1721-1731.
21. A.V. Rubtsov, K. Rubtsova, J.W. Kappler, P. Marrack, TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice, Immunol. Res. (2012).
22. P. Pisitkun, J.A. Deane, M.J. Difilippantonio, T. Tarasenko, A.B. Satterthwaite, S. Bolland, Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication, Science 312 (2006) 1669-1672.
23. J.A. Deane, P. Pisitkun, R.S. Barrett, L. Feigenbaum, T. Town, J.M. Ward, R.A. Flavell, S. Bolland, Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation, Immunity 27 (2007) 801-810.
24. S.H. Hwang, H. Lee, M. Yamamoto, L.A. Jones, J. Dayalan, R. Hopkins, X.J. Zhou, F. Yarovinsky, J.E. Connolly, M.A. Curotto de Lafaille, E.K. Wakeland, A.M. Fairhurst, B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice, J. Immunol. 189 (2012) 5786-5796.
25. E.R. Walsh, P. Pisitkun, E. Voynova, J.A. Deane, B.L. Scott, R.R. Caspi, S. Bolland, Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity, Proc. Natl. Acad. Sci. U.S.A. 109 (2012) 16276-16281.
26. A. Komatsuda, H. Wakui, K. Iwamoto, M. Ozawa, M. Togashi, R. Masai, N. Maki, T. Hatakeyama, K. Sawada, Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus, Clin. Exp. Immunol. 152 (2008) 482-487.
27. H. Garcia-Ortiz, R. Velazquez-Cruz, F. Espinosa-Rosales, S. Jimenez-Morales, V. Baca, L. Orozco, Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population, Ann. Rheum. Dis. 69 (2010) 1861-1865.
28. J. Kelley, M.R. Johnson, G.S. Alarcon, R.P. Kimberly, J.C. Edberg, Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects, Arthritis Rheum. 56 (2007) 3375-3378.
29. R.H. Scofield, G.R. Bruner, B. Namjou, R.P. Kimberly, R. Ramsey-Goldman, M. Petri, J.D. Reveille, G.S. Alarcon, L.M. Vila, J. Reid, B. Harris, S. Li, J.A. Kelly, J.B. Harley, Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome, Arthritis Rheum. 58 (2008) 2511-2517.
30. C. Haas, B. Ryffel, M. Le Hir, IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice, J. Immunol. 158 (1997) 5484-5491.
31. A. Schwarting, T. Wada, K. Kinoshita, G. Tesch, V.R. Kelley, IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice, J. Immunol. 161 (1998) 494-503.
32. D. Balomenos, R. Rumold, A.N. Theofilopoulos, Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice, J. Clin. Investig. 101 (1998) 364-371.
33. C. Haas, B. Ryffel, M. Le Hir, IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB × NZW)F1 mice, J. Immunol. 160 (1998) 3713-3718.
34. C.O. Jacob, P.H. van der Meide, H.O. McDevitt, In vivo treatment of (NZB × NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon, J. Exp. Med. 166 (1987) 798-803.
35. J.P. Seery, J.M. Carroll, V. Cattell, F.M. Watt, Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis, J. Exp. Med. 186 (1997) 1451-1459.
36. S.K. Lee, D.G. Silva, J.L. Martin, A. Pratama, X. Hu, P.P. Chang, G. Walters, C.G. Vinuesa, Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers, Immunity 37 (2012) 880-892.
37. A.N. Theofilopoulos, S. Koundouris, D.H. Kono, B.R. Lawson, The role of IFNgamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity, Arthritis Res. 3 (2001) 136-141.
38. A. Csiszar, G. Nagy, P. Gergely, T. Pozsonyi, E. Pocsik, Increased interferongamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE), Clin. Exp. Immunol. 122 (2000) 464-470.
39. T.R. Radstake, L. van Bon, J. Broen, A. Hussiani, R. Hesselstrand, D.M. Wuttge, Y. Deng, R. Simms, E. Lubberts, R. Lafyatis, The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes, PLoS ONE 4 (2009) e5903.
40. P. Willeke, B. Schluter, H. Schotte, W. Domschke, M. Gaubitz, H. Becker, Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon, Semin. Arthritis Rheum. 39 (2009) 197-202.
41. C.M. Pelfrey, A.C. Cotleur, J.C. Lee, R.A. Rudick, Sex differences in cytokine responses to myelin peptides in multiple sclerosis, J. Neuroimmunol. 130 (2002) 211-223.
42. C.F. Pinzan, L.P. Ruas, A.S. Casabona-Fortunato, F.C. Carvalho, M.C. Roque-Barreira, Immunological basis for the gender differences in murine Paracoccidioides brasiliensis infection, PLoS ONE 5 (2010) e10757.
43. A. Satoskar, J. Alexander, Sex-determined susceptibility and differential IFNgamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana, Immunology 84 (1995) 1-4.
44. J. Wang, J.W. Fathman, G. Lugo-Villarino, L. Scimone, U. von Andrian, D.M. Dorfman, L.H. Glimcher, Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells, J. Clin. Investig. 116 (2006) 414-421.
45. E. Bettelli, B. Sullivan, S.J. Szabo, R.A. Sobel, L.H. Glimcher, V.K. Kuchroo, Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis, J. Exp. Med. 200 (2004) 79-87.
46. J.H. Esensten, M.R. Lee, L.H. Glimcher, J.A. Bluestone, T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function, J. Immunol. 183 (2009) 75-82.
47. S.L. Peng, S.J. Szabo, L.H. Glimcher, T-bet regulates IgG class switching and pathogenic autoantibody production, Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5545-5550.
48. O.H. Hultgren, M. Verdrengh, A. Tarkowski, T-box transcription-factordeficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis, Microbes Infect. 6 (2004) 529-535.